In OT cohort tumor samples, we found up regulation of ASPN in 26 out of 42 samples (61.9%; Fig 3B), while DCN was down regulated in 22 out of 42 samples (52.4%; S1 Fig). The gene discussed is ASPN; the disease is neoplasm.